A research team at King’s College London is launching a Phase 2 trial of a cannabis-based therapy for the treatment of certain dementia symptoms, according to a Friday announcement by Alzheimer’s Research UK, which will be funding the study.
MarketWatch.com - Top Stories, MarketWatch
Fri, 02/15/2019 - 12:39pm
A research team at King’s College London is launching a Phase 2 trial of a cannabis-based therapy for the treatment of certain dementia symptoms, according to a Friday announcement by Alzheimer’s Research UK, which will be funding the study.